Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Invitae Corp NVTAQ

Healthcare
Invitae Corporation is a medical genetics company. The Company is engaged in delivering genetic testing services, digital health solutions, and health data services that support a lifetime of patient care and improved outcomes. It offers genetic testing across multiple clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases and pharmacogenomics. It applies... see more

Recent & Breaking News (GREY:NVTAQ)

Invitae Appoints Robert Nussbaum, M.D., as Chief Medical Officer

Business Wire April 27, 2015

Invitae Presents New Data Demonstrating Use of Next-Generation Sequencing for Multi-Gene Panels at the 2015 American College of Medical Genetics Annual Clinical Genetics Meeting

Business Wire March 26, 2015

Invitae to Present Seven Posters Highlighting New Data on the Use of Next-Generation Sequencing for Multi-Gene Panels at the 2015 American College of Medical Genetics Annual Clinical Genetics Meeting

Business Wire March 17, 2015

Invitae Announces Fourth Quarter and 2014 Year-End Financial Results and Highlights and Provides 2015 Outlook

Business Wire March 10, 2015

Invitae to Announce Fourth Quarter and Year-End 2014 Financial Results and Host Conference Call on March 10, 2015

Business Wire February 24, 2015

Invitae Announces Completion of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Business Wire February 18, 2015

Invitae Announces Pricing of Initial Public Offering of Common Stock

Business Wire February 11, 2015